(Q44454008)

English

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in pat

scientific article published in June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in pat (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

author name string

Corrado Tarella

1

1 reference

Europe PubMed Central

3 December 2017

Alessandra Cuttica

2

1 reference

Europe PubMed Central

3 December 2017

Umberto Vitolo

3

1 reference

Europe PubMed Central

3 December 2017

Marina Liberati

4

1 reference

Europe PubMed Central

3 December 2017

Massimo Di Nicola

5

1 reference

Europe PubMed Central

3 December 2017

Sergio Cortelazzo

6

1 reference

Europe PubMed Central

3 December 2017

Rosalba Rosato

7

1 reference

Europe PubMed Central

3 December 2017

Carlo Rosanelli

8

1 reference

Europe PubMed Central

3 December 2017

Nicola Di Renzo

9

1 reference

Europe PubMed Central

3 December 2017

Maurizio Musso

10

1 reference

Europe PubMed Central

3 December 2017

Enzo Pavone

11

1 reference

Europe PubMed Central

3 December 2017

Gino Santini

12

1 reference

Europe PubMed Central

3 December 2017

Alessandra Pescarollo

13

1 reference

Europe PubMed Central

3 December 2017

Alberto De Crescenzo

14

1 reference

Europe PubMed Central

3 December 2017

Massimo Federico

15

1 reference

Europe PubMed Central

3 December 2017

Massimo Federico

16

1 reference

Europe PubMed Central

3 December 2017

Andrea Gallamini

17

1 reference

Europe PubMed Central

3 December 2017

Patrizia Pregno

18

1 reference

Europe PubMed Central

3 December 2017

Roberta Romano

19

1 reference

Europe PubMed Central

3 December 2017

Paolo Coser

20

1 reference

Europe PubMed Central

3 December 2017

Eugenio Gallo

21

1 reference

Europe PubMed Central

3 December 2017

Mario Boccadoro

22

1 reference

Europe PubMed Central

3 December 2017

Tiziano Barbui

23

1 reference

Europe PubMed Central

3 December 2017

Alessandro Pileri

24

1 reference

Europe PubMed Central

3 December 2017

Alessandro M Gianni

25

1 reference

Europe PubMed Central

3 December 2017

Alessandro Levis

26

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

97

1 reference

Europe PubMed Central

3 December 2017

11

1 reference

Europe PubMed Central

3 December 2017

2748-2759

1 reference

Europe PubMed Central

3 December 2017

The place of high-dose therapy with haemopoietic stem cell transplantation in relapsed and refractory Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of autotransplantation in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of relapsed Hodgkin's disease patients with high-dose chemotherapy and marrow stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11414

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11414

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44454008&oldid=2080769156"